Peptide Blood Work Guide: What Tests You Need

Key Takeaways

Baseline labs are essential — Always get comprehensive blood work before starting any peptide protocol to establish your personal reference ranges.
Monitor regularly — Repeat key panels every 8–12 weeks during peptide use to catch changes early.
GH-related markers matter most — IGF-1, fasting glucose, and insulin are critical when using growth hormone secretagogues.
Liver and kidney panels are non-negotiable — These organs process peptides, and you need to confirm they're functioning well.
Use our bloodwork tool — Visit peptideplaybook.health/bloodwork for a personalized lab checklist based on your protocol.

Why Blood Work Matters for Peptide Users

Peptides are powerful bioactive compounds that interact with your endocrine system, metabolism, and organ function. Unlike basic supplements, peptides can meaningfully shift hormone levels, insulin sensitivity, and growth factor production. Without blood work, you're essentially flying blind — unable to confirm whether your protocol is working, whether doses need adjustment, or whether any adverse changes are occurring beneath the surface.

Think of blood work as your internal dashboard. Just as you wouldn't drive a car without a speedometer and fuel gauge, you shouldn't run a peptide protocol without objective biomarker data. This guide walks you through every test you need, when to get them, and how to interpret the results in the context of peptide therapy.

Whether you're using BPC-157 for recovery, CJC-1295/Ipamorelin for growth hormone optimization, or semaglutide for metabolic health, the right lab panels will keep you safe and help you get better results.

Baseline Blood Work: What to Get Before You Start

Before initiating any peptide protocol, you need a comprehensive baseline. This snapshot tells you where your body stands right now, so you can measure changes accurately over time. Here's what to include:

Complete Metabolic Panel (CMP)

The CMP covers 14 essential measurements including glucose, electrolytes, kidney function markers (BUN, creatinine), and liver enzymes (ALT, AST, ALP). This is your foundational panel — it tells you whether your liver and kidneys are healthy enough to process peptides safely.

Pay special attention to fasting glucose. Many growth hormone secretagogues can transiently raise blood sugar, so knowing your starting point is critical. If your fasting glucose is already elevated (above 100 mg/dL), you'll need to monitor this more frequently.

Complete Blood Count (CBC)

A CBC measures red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. While peptides don't typically cause dramatic hematological changes, certain protocols — especially those involving GH secretagogues — can influence red blood cell production. A baseline CBC helps you spot any unexpected shifts.

Lipid Panel

Total cholesterol, LDL, HDL, and triglycerides should all be measured at baseline. Growth hormone optimization can improve lipid profiles over time, but you need a starting reference to measure that improvement. Some peptides may also interact with metabolic pathways that influence lipid metabolism.

Hormone Panel

Depending on your protocol, you'll want some or all of the following:

IGF-1 — The single most important marker for GH secretagogue users. IGF-1 reflects your body's integrated growth hormone output over time. Target ranges vary by age, but most adults aim for the upper-middle quartile of the reference range.
Testosterone (total and free) — Some peptides indirectly support testosterone production. Baseline values let you track this benefit.
Estradiol — Important for both men and women, especially when hormonal peptides are involved.
Thyroid panel (TSH, free T3, free T4) — Growth hormone can influence thyroid hormone conversion. Baseline thyroid values are essential.
Cortisol (morning) — Stress hormones interact with nearly every peptide pathway. Know your starting cortisol level.

Fasting Insulin

This is often overlooked but incredibly important. Fasting insulin is a far more sensitive marker of metabolic health than fasting glucose alone. Many peptide users are optimizing for body composition and metabolic function — fasting insulin tells you how well your body is actually handling glucose at the cellular level.

Pair this with fasting glucose to calculate your HOMA-IR score, a simple measure of insulin resistance. A HOMA-IR below 1.0 is optimal; above 2.0 suggests meaningful insulin resistance that should be addressed.

Inflammatory Markers

Consider adding hs-CRP (high-sensitivity C-reactive protein) and ESR (erythrocyte sedimentation rate) to your baseline. If you're using peptides like BPC-157 or TB-500 for healing and recovery, these inflammation markers help you track whether the protocol is actually reducing systemic inflammation.

Protocol-Specific Lab Panels

Different peptides warrant different monitoring. Here's a breakdown by category:

Growth Hormone Secretagogues (CJC-1295, Ipamorelin, MK-677, Tesamorelin)

These peptides stimulate your pituitary to release more growth hormone. The key markers to watch:

IGF-1 — Check at baseline, 4 weeks, and every 8–12 weeks. Rising IGF-1 confirms the protocol is working. Excessively high IGF-1 (well above age-adjusted reference) means you should reduce dosing.
Fasting glucose and insulin — GH raises blood sugar. Monitor these closely, especially with MK-677 which has the strongest glucose impact.
HbA1c — Add this at baseline and every 3 months. It gives you a 90-day average of blood sugar control.
Thyroid panel — GH can increase T4-to-T3 conversion. Monitor for any thyroid shifts.

GLP-1 Receptor Agonists (Semaglutide, Tirzepatide)

For metabolic and weight management peptides:

Fasting glucose, insulin, and HbA1c — These should improve. Track the improvement.
Lipid panel — Expect improvements in triglycerides and sometimes LDL.
Liver enzymes (ALT, AST) — GLP-1 agonists can improve fatty liver, but monitor liver function regardless.
Amylase and lipase — Important to rule out pancreatic inflammation, a rare but serious side effect.
Kidney function (BUN, creatinine, eGFR) — Especially important if you have any pre-existing kidney concerns.

Healing Peptides (BPC-157, TB-500)

These peptides are generally well-tolerated, but still warrant basic monitoring:

SponsoredPartner with us — advertise hereContact us

CMP and CBC — Standard safety panels.
hs-CRP and ESR — Track inflammation reduction.
Liver enzymes — BPC-157 is hepatoprotective in research, but individual responses vary.

When to Get Blood Work

Timing matters. Here's the recommended schedule:

Baseline — 1–2 weeks before starting your peptide protocol. This gives you clean reference values.
4-week check — A focused mini-panel (IGF-1, glucose, insulin, liver enzymes) to catch any early changes. This is especially important for first-time users.
8–12 week comprehensive panel — Repeat your full baseline panel. Compare everything side by side.
Ongoing monitoring — Every 3–4 months for the duration of your protocol. You can alternate between comprehensive and focused panels to manage cost.
Post-cycle — Get blood work 4–6 weeks after discontinuing a peptide to confirm your markers return to baseline.

Always get fasting blood work — at least 10–12 hours without food. Morning draws (before 10 AM) are ideal for hormones, as many fluctuate throughout the day.

How to Order and Interpret Your Labs

You have several options for ordering blood work:

Through your physician — The gold standard. Your doctor can order, interpret, and act on results.
Direct-to-consumer lab services — Companies like Quest, Labcorp, and various online panels allow you to order labs without a doctor's visit. Results come directly to you.
Telehealth clinics — Many peptide-focused telehealth providers include lab monitoring as part of their programs.

When reading results, don't just look at whether values fall within the "normal" reference range. Those ranges are based on population averages and include unhealthy people. Instead, aim for optimal ranges — the values associated with peak health and longevity. For example, while a fasting glucose of 99 mg/dL is technically "normal," most longevity-focused practitioners prefer to see it below 90 mg/dL.

Use our bloodwork interpretation tool to get personalized insights based on your specific peptide protocol and lab results.

Red Flags: When to Stop and Consult a Doctor

Certain lab changes should prompt you to pause your protocol and seek medical guidance:

Liver enzymes (ALT/AST) rising above 2x the upper limit of normal — This suggests liver stress that needs evaluation.
Fasting glucose consistently above 110 mg/dL — Especially concerning with GH secretagogues. May need dose reduction or protocol change.
IGF-1 significantly above the age-adjusted reference range — Chronically elevated IGF-1 carries potential long-term risks. Reduce dose.
Kidney markers (creatinine, BUN) trending upward — Could indicate kidney stress.
Amylase or lipase elevated above normal — Potential pancreatic concern, especially with GLP-1 agonists. Stop use and consult a physician immediately.
Any dramatic shift in CBC values — Unexpected changes in blood cell counts warrant investigation.

Remember: peptides are tools, not magic. They work best within a framework of responsible monitoring and professional medical guidance.

Cost-Saving Tips for Regular Lab Work

Regular blood work can get expensive. Here are strategies to manage costs:

Use direct-to-consumer panels — Often 50–70% cheaper than hospital labs for the same tests.
Bundle strategically — Order comprehensive panels rather than individual tests; the per-test cost is usually lower.
Alternate comprehensive and focused panels — You don't need every test every time. Rotate between full panels and targeted checks.
Ask about cash-pay pricing — Labs often have significantly lower cash prices compared to insurance-billed rates.
Time it right — Many lab companies run seasonal sales, especially around New Year and summer wellness campaigns.

Building Your Personalized Lab Protocol

Every person and every peptide protocol is different. The best approach is to build a monitoring plan tailored to your specific situation. Consider your:

Age and baseline health — Older users or those with pre-existing conditions need more frequent and comprehensive monitoring.
Specific peptides being used — GH secretagogues need different panels than healing peptides.
Duration of use — Longer protocols warrant more checkpoints.
Stacking — Using multiple peptides simultaneously increases the importance of comprehensive monitoring.
Personal health goals — Track the markers most relevant to what you're trying to achieve.

Visit peptideplaybook.health/bloodwork to generate a customized lab checklist based on your protocol. Simply enter the peptides you're using, and the tool will recommend exactly which tests to order and when.

For more peptide education, explore our peptide glossary to understand the terminology, or browse the Peptide Playbook for comprehensive guides on specific peptides and protocols.

Conclusion

Blood work isn't optional for responsible peptide use — it's foundational. By establishing baseline values, monitoring key biomarkers throughout your protocol, and knowing the red flags that warrant medical attention, you protect your health while maximizing the benefits of peptide therapy.

Start with a comprehensive baseline panel, follow up at 4 weeks with focused labs, and continue monitoring every 8–12 weeks. Use the protocol-specific recommendations in this guide to customize your approach, and always work with a qualified healthcare provider when possible.

Your body is giving you data. Blood work is how you read it.

Medical Disclaimer: This article is for informational and educational purposes only. It is not medical advice and should not be used to diagnose, treat, or prevent any disease or condition. Peptides are research compounds and their use may not be approved by regulatory agencies in your jurisdiction. Always consult with a qualified healthcare provider before starting any peptide protocol or making changes to your health regimen. Individual results may vary. Peptide Playbook does not endorse the use of any compound without proper medical supervision.